However, important limitations exist in the current evidence: Most studies have been relatively small with short follow-up periods Many participants had concurrent obesity, making it difficult to separate weight loss effects from direct effects on binge eating behaviour Long-term efficacy and safety data specifically for binge eating disorder are lacking The psychological and behavioural components of BED may require interventions beyond pharmacological appetite suppression There is no official link established by regulatory bodies between GLP-1 agonists and binge eating disorder treatment
Water Resistance: The sensor can withstand immersion in water, so its safe to swim, shower, or engage in physical activities
Lifestyle changes, like eating healthier and exercising more, are essential for optimal effectiveness and to improve your chances of maintaining a healthy weight after you stop taking the medication. As an RD, I appreciate that Ro Body offers a convenient way for people to access GLP-1 medications to assist with their weight loss efforts
We would strongly advise against it
How to Switch From Brand-Name to Compounded GLP-1 Introduction Switching from brand-name Wegovy or Zepbound to compounded semaglutide or tirzepatide is a common decision in 2026, usually driven by cost